MRP is a recently identified ATP-binding cassette transporter. We prev
iously established that MRP confers resistance to a spectrum of natura
l product cytotoxic drugs [Kruh, G. D., (1994) Cancer Res. 54, 1649-16
52], that expression of MRP is associated with enhanced drug efflux [B
reuninger, L. M., (1995) Cancer Res. 55, 5342-5347], and that MRP tran
script is widely expressed in human tissues and solid tumor cell lines
[Kruh, G. D., (1995) J. Natl. Cancer Inst. 87, 1256-1258]. In the pre
sent study the relationship between MRP and drug glutathione S-conjuga
tes was examined. We observed that MRP was labeled by azidophenacylglu
tathione (APA-SG), a photoaffinity analog of glutathione, and that ins
ide-out membrane vesicles prepared from MRP-overexpressing HL60/ADR ce
lls transported this compound. Transport into membrane vesicles was AT
P-dependent, sensitive to osmolarity, and saturable with regard to APA
-SG and ATP concentrations, with K-m values of 15 and 61 mu M, respect
ively. APA-SG transport was competitively inhibited by the natural pro
duct cytotoxic drugs daunorubicin, vincristine, and etoposide, with K-
i values of 4.8, 3.8, and 5.5 mu M, respectively. Oxidized glutathione
, the drug-glutathione S-conjugate DNP-SG, the LTD(4) antagonist MK571
and arsenate were also competitive inhibitors, with K-i values of 9.0
, 23.4, 1.1, and 15.0 mu M, respectively. Analysis of the fate of mono
chlorobimane in MRP transfectants revealed reduced intracellular conce
ntrations of drug-glutathione S-conjugates associated with enhanced ef
flux and altered intracellular distribution. These results indicate th
at MRP can transport glutathione conjugates in vitro and in living cel
ls and suggest the possibility that the transporter may represent a li
nk between cellular resistance to some classes of cytotoxic drugs and
glutathione-mediated mechanisms of resistance. In addition, the observ
ation that both mildly cationic or neutral natural product cytotoxic d
rugs and anionic compounds such as DNP-SG, MK571, and arsenate are com
petitive inhibitors of MRP action suggests that the substrate specific
ity of the transporter is quite broad.